ArticleFrontiers in medicine2023

Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data.

Eleni Gavriilaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.